Dynamic Interference Testing—Unexpected Results Obtained with the Abbott Libre 2 and Dexcom G6 Continuous Glucose Monitoring Devices
Our standardized dynamic interference testing protocol identified several nutritional, pharmaceutical and endogenous substances that substantially influenced L2 and G6 sensor signals. Clinical trials are now necessary to investigate whether our findings are of relevance during routine care.
Authors
- Hendrick Jensch
- Mike Grady (ORCID: https://orcid.org/0000-0002-8006-1844)
- Elizabeth H. Holt (ORCID: https://orcid.org/0000-0003-4329-3379)
- Andreas Pfützner (ORCID: https://orcid.org/0000-0003-2385-0887)
- Nicole Thomé
- Steven Setford (ORCID: https://orcid.org/0000-0003-1983-0461)
- Geethan Srikanthamoorthy
- Lea Weingärtner
Institutions
- TH Bingen University of Applied Sciences (DE)
- University of Luxembourg (LU)
- NovaBiotics (United Kingdom) (GB)
Publication Details
- Journal
- Sensors
- Published
- 2025-03-22
- DOI
- https://doi.org/10.3390/s25071985
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.59